Lamitor OD 25 Tablet SR contains Lamotrigine 25 mg as its active ingredient and is indicated primarily for the management of epilepsy and bipolar disorder. Lamotrigine is an anticonvulsant that stabilizes neuronal membranes by inhibiting voltage-sensitive sodium channels, thereby reducing the release of excitatory neurotransmitters such as glutamate. This mechanism helps in controlling partial seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Additionally, Lamitor OD 25 is effective as a mood stabilizer in the maintenance treatment of bipolar disorder, helping to delay the occurrence of mood episodes. The sustained-release formulation ensures a gradual release of the drug, promoting consistent plasma levels and improving patient compliance by enabling once-daily dosing. It is essential to initiate Lamitor OD 25 at a low dose and titrate gradually to minimize the risk of serious skin rashes, including Stevens-Johnson syndrome. Common adverse effects may include dizziness, headache, blurred vision, and gastrointestinal disturbances. Lamitor OD 25 should be used under medical supervision, with careful monitoring for hypersensitivity reactions and potential drug interactions, particularly with valproate and other antiepileptic agents. It is contraindicated in patients with known hypersensitivity to Lamotrigine or any formulation components.